NCT01936025View on ClinicalTrials.gov

A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Dextromethorphan

DRUG

Sitagliptin

DRUG

Placebo

Trial Locations (1)

41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

All Listed Sponsors
lead

Profil Institut für Stoffwechselforschung GmbH

INDUSTRY

NCT01936025 - A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test | Biotech Hunter | Biotech Hunter